Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1ion Aug 31, 2023 1:48pm
91 Views
Post# 35614187

RE:RE:Got some good inside info from eyes in the sky...massive "3"

RE:RE:Got some good inside info from eyes in the sky...massive "3"Tax income has big potential but what about $1.5+ trillion the U.S. spends annually out of their budget on health care costs?  Reducing those cost through short or no hospital stays is also a form of money for the government.    Let me give you an example:  A package of active pharmaceutical ingredients put inside of a delivery vessel and the vessel is conjugated with another molecule that specifically seeks out a cancer cell be it floating through your body in your blood stream or form of a solid tumor without affecting healthy cells.   The package is taken orally in pill form.   Well documented research from U of Technion, in one example, making breast tumors disappear without the need for a scalpel, surgery, chemotherapy, and lengthy hospital stays....those are the big elephant savings to the U.S. government far above tax revenues.   

Please read this article below, and not by coincidence either, Dr. Peer of EPM (acid cannabinoids under Dr. Mechoulam) visited Canada and briefly talked about targeting mechanism delivery a payload to kill only cancer cells.   Work was done at City of Hope oncology research center in Califormia and also involved Pfizer.   The same Pfizer that took out Seagen with a developed targeting mechanism and the same Pfizer that took out Arena Pharma with a pipeline containing cannbinoid based drugs. 

It's a small world and I'm justing wating for the traditional global pharma partner party in Barrie. 

Here's the article  https://www.nzherald.co.nz/lifestyle/scientists-praise-holy-grail-cancer-breakthrough-as-new-drug-annihilates-tumours/H6EXSTXURVHF7PCKNNSDX4BNXE/

That pill alone is worth $billions, including the one supplying the pharmaceutical API's.   
<< Previous
Bullboard Posts
Next >>